Cancer trends and risk factors in Cyprus

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Cyprus, a European Union member state, is a small island in the Mediterranean with a population approaching 900,000 people. Cancer is the second leading cause of death; more therapeutic options for any patient with the disease are available in a central oncology centre in the capital of the island (Nicosia) and fewer therapeutic options (e.g. chemotherapy and hormone therapy only) in a few other public hospitals. Palliative care is offered in several hospices and hospitals, although the field needs improvement. With regards to screening, a national breast cancer screening programme has been in place countrywide since 2007 and is offered free of charge to women between the ages of 50 and 69 years, while colorectal and prostate cancer screening is performed on an individual basis (a pilot programme for colorectal cancer screening was recently initiated). Genetic testing is available for breast and colon cancer. To improve understanding of the causes of cancer in the country, a cancer research centre was established in 2010 (Mediterranean Centre for Cancer Research). Recent epidemiologic work has revealed increasing cancer trends in Cyprus; prostate cancer is the most common in men and breast cancer is the most common in women. Interestingly, thyroid cancer incidence in women has been rising from 1998 to 2008. Cancer of the colon and rectum is also on the rise affecting both sexes. Overall, cancer incidence in Cyprus is lower than other EuroMed countries with similar lifestyle and geography.

Original languageEnglish (US)
Article number389
Journalecancermedicalscience
Volume8
Issue number1
DOIs
StatePublished - Jan 24 2014

Fingerprint

Cyprus
Early Detection of Cancer
Neoplasms
Breast Neoplasms
Colonic Neoplasms
Colorectal Neoplasms
Mediterranean Islands
Prostatic Neoplasms
Mobile Health Units
Geography
Hospices
Second Primary Neoplasms
Public Hospitals
Incidence
Genetic Testing
European Union
Rectal Neoplasms
Palliative Care
Thyroid Neoplasms
Research

Keywords

  • Cancer
  • Cancer incidence
  • Cyprus
  • Risk factors

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Cancer trends and risk factors in Cyprus. / Farazi, Paraskevi A.

In: ecancermedicalscience, Vol. 8, No. 1, 389, 24.01.2014.

Research output: Contribution to journalArticle

@article{7bfa3a5f57c54d20a69946b6f409c077,
title = "Cancer trends and risk factors in Cyprus",
abstract = "Cyprus, a European Union member state, is a small island in the Mediterranean with a population approaching 900,000 people. Cancer is the second leading cause of death; more therapeutic options for any patient with the disease are available in a central oncology centre in the capital of the island (Nicosia) and fewer therapeutic options (e.g. chemotherapy and hormone therapy only) in a few other public hospitals. Palliative care is offered in several hospices and hospitals, although the field needs improvement. With regards to screening, a national breast cancer screening programme has been in place countrywide since 2007 and is offered free of charge to women between the ages of 50 and 69 years, while colorectal and prostate cancer screening is performed on an individual basis (a pilot programme for colorectal cancer screening was recently initiated). Genetic testing is available for breast and colon cancer. To improve understanding of the causes of cancer in the country, a cancer research centre was established in 2010 (Mediterranean Centre for Cancer Research). Recent epidemiologic work has revealed increasing cancer trends in Cyprus; prostate cancer is the most common in men and breast cancer is the most common in women. Interestingly, thyroid cancer incidence in women has been rising from 1998 to 2008. Cancer of the colon and rectum is also on the rise affecting both sexes. Overall, cancer incidence in Cyprus is lower than other EuroMed countries with similar lifestyle and geography.",
keywords = "Cancer, Cancer incidence, Cyprus, Risk factors",
author = "Farazi, {Paraskevi A.}",
year = "2014",
month = "1",
day = "24",
doi = "10.3332/ecancer.2014.389",
language = "English (US)",
volume = "8",
journal = "ecancermedicalscience",
issn = "1754-6605",
publisher = "Cancer Intellilgence",
number = "1",

}

TY - JOUR

T1 - Cancer trends and risk factors in Cyprus

AU - Farazi, Paraskevi A.

PY - 2014/1/24

Y1 - 2014/1/24

N2 - Cyprus, a European Union member state, is a small island in the Mediterranean with a population approaching 900,000 people. Cancer is the second leading cause of death; more therapeutic options for any patient with the disease are available in a central oncology centre in the capital of the island (Nicosia) and fewer therapeutic options (e.g. chemotherapy and hormone therapy only) in a few other public hospitals. Palliative care is offered in several hospices and hospitals, although the field needs improvement. With regards to screening, a national breast cancer screening programme has been in place countrywide since 2007 and is offered free of charge to women between the ages of 50 and 69 years, while colorectal and prostate cancer screening is performed on an individual basis (a pilot programme for colorectal cancer screening was recently initiated). Genetic testing is available for breast and colon cancer. To improve understanding of the causes of cancer in the country, a cancer research centre was established in 2010 (Mediterranean Centre for Cancer Research). Recent epidemiologic work has revealed increasing cancer trends in Cyprus; prostate cancer is the most common in men and breast cancer is the most common in women. Interestingly, thyroid cancer incidence in women has been rising from 1998 to 2008. Cancer of the colon and rectum is also on the rise affecting both sexes. Overall, cancer incidence in Cyprus is lower than other EuroMed countries with similar lifestyle and geography.

AB - Cyprus, a European Union member state, is a small island in the Mediterranean with a population approaching 900,000 people. Cancer is the second leading cause of death; more therapeutic options for any patient with the disease are available in a central oncology centre in the capital of the island (Nicosia) and fewer therapeutic options (e.g. chemotherapy and hormone therapy only) in a few other public hospitals. Palliative care is offered in several hospices and hospitals, although the field needs improvement. With regards to screening, a national breast cancer screening programme has been in place countrywide since 2007 and is offered free of charge to women between the ages of 50 and 69 years, while colorectal and prostate cancer screening is performed on an individual basis (a pilot programme for colorectal cancer screening was recently initiated). Genetic testing is available for breast and colon cancer. To improve understanding of the causes of cancer in the country, a cancer research centre was established in 2010 (Mediterranean Centre for Cancer Research). Recent epidemiologic work has revealed increasing cancer trends in Cyprus; prostate cancer is the most common in men and breast cancer is the most common in women. Interestingly, thyroid cancer incidence in women has been rising from 1998 to 2008. Cancer of the colon and rectum is also on the rise affecting both sexes. Overall, cancer incidence in Cyprus is lower than other EuroMed countries with similar lifestyle and geography.

KW - Cancer

KW - Cancer incidence

KW - Cyprus

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=84894550375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894550375&partnerID=8YFLogxK

U2 - 10.3332/ecancer.2014.389

DO - 10.3332/ecancer.2014.389

M3 - Article

C2 - 24678344

AN - SCOPUS:84894550375

VL - 8

JO - ecancermedicalscience

JF - ecancermedicalscience

SN - 1754-6605

IS - 1

M1 - 389

ER -